Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2016
Home
2016
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Change of Directors Interest Notice – Maria Halasz
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
European Midkine Patent for Surgical Adhesion Allowed
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Expiry of Listed Options (CDYO)
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Quotation of Listed Options
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
2016 Annual Report
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid’s Midkine Antibodies Show Anti-tumor Activity Against Brain Cancer
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmid Records Highest Ever Quarterly Sales For Evolis®
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Change of Directors Interest Notice – Maria Halasz
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Change of Directors Interest Notice – David King
Prev page
1
2
3
4
5
6
Next page
